BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 4, 2007
View Archived Issues
New data provided by EAE models for multiple sclerosis
Read More
New clinical trial results for rotigotine in Parkinson's disease, restless legs syndrome
Read More
Antitumor activity of novel PI3K inhibitor reported by Zentaris
Read More
Novel CDK inhibitor SCH-727965 shows broad antitumor activity in preclinical studies
Read More
New therapeutic agents for benign prostatic hyperplasia disclosed in recent Ranbaxy patent
Read More
Recent data suggest that lacosamide has low potential for drug-drug interaction
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Novel agents for cardiovascular disorders disclosed in recent Taisho and Boehringer patents
Read More
Biosite and Beckman Coulter amend merger agreement
Read More
Phase Ib study to begin for optimized TPM-02/Insulin
Read More
Cardiome Pharma in-licenses GED-aPC
Read More
Rituximab beneficial in myositis, polyneuropathy, neuromyelitis optica
Read More
Laquinimod reduces disease activity in relapsing-remitting MS
Read More
Phase III trial finds Imagify non-inferior to nuclear stress
Read More
Positive phase I findings for DG-051 for prevention of heart attack
Read More
Schering-Plough reviews Q1
Read More
TH-302 demonstrates activity in orthotopic models of cancer
Read More
Pro-Pharmaceuticals and Digna collaborate in hepatitis C
Read More
ViroPharma to establish European subsidiary for maribavir
Read More
Ark seeks clearance for phase III study of Trinam
Read More
ThromboGenics reviews preclinical pipelines progression
Read More
Target enrollment reached in phase IIb study of ozarelix for BPH
Read More
Cadence plans to increase patient numbers in phase III Omnigard trial
Read More
Enrollment under way in phase II study of FTY-720 for relapsing-remitting MS
Read More
Belinostat studied with doxorubicin in new phase I/II trial for soft tissue sarcomas
Read More
Enzon cleared to begin phase I study of PEG-SN38 in cancer
Read More
Tbeta4 cleared for phase II study in diabetics undergoing vitrectomy surgery
Read More
Herceptin approved for new breast cancer indication in E.U.
Read More
Supprelin-LA approved for central precocious puberty
Read More
